2009 Annual Meeting | Attention Deficit Hyperactivity Disorder Across the Lifespan

��ɫ��

2009 Annual Meeting | Attention Deficit Hyperactivity Disorder Across the Lifespan

Date Friday 05/01/09

Time 06:45 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Breakfast Seminar

Director(s) Martha B. Denckla, MD

Topic(s)

Learning Objectives Participants should be able to recognize the clinical features of ADHD during key ages in the lifespan; understand the neurobiological basis and core neuropsychologic underpinnings of ADHD and their impact on clinical manifestations; know the available treatment options (pharmacologic and nonpharmacologic) for ADHD and common comorbid conditions at various ages; and determine treatment options when ADHD co-occurs with neurologic conditions such as tic disorder and epilepsy.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
06:45 AM - 07:15 AM		Diagnostic Issues Max Wiznitzer, MD, FAAN
06:45 AM - 08:30 AM		Breakfast
07:15 AM - 07:45 AM		Neuroscience and the Basis for Pharmological Treatment Martha B. Denckla, MD
07:45 AM - 08:05 AM		Pharmological Treatment Max Wiznitzer, MD, FAAN
08:05 AM - 08:30 AM		Non-Pharmological Treatments Martha B. Denckla, MD

Faculty Disclosures
Martha B. Denckla, MD	No disclosure on file
Max Wiznitzer, MD, FAAN	Dr. Wiznitzer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Department of Health and Human Services - Vaccine Injury Compensation Program. Dr. Wiznitzer has a non-compensated relationship as a Board of Directors with CHADD that is relevant to AAN interests or activities.

��ɫ����

��ɫ����

��ɫ��

��ɫ��